Published in Medical Patent Week, March 20th, 2005
QuickMass-enhanced targets enable MALDI mass spectrometers to be used for accurate and convenient small molecule analysis using matrix-less and thin-layer matrix test techniques.
"In applications where the mass range limits of MALDI mass spectrometers have forced analytic chemists to use slower and costlier analytic protocols, QuickMass-enhanced targets enable a leap in productivity and capability," said Dr. Stephen Fonash, founder of NanoHorizons. "Tens of millions of compounds are...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.